Michael Taylor on Bridging Science and Finance, Breast Cancer Philanthropy, and Healthcare Investment Innovations

Michael Taylor, PM of the Pink Fund, shares his extraordinary journey from the lab to the world of finance, bringing a unique perspective on investment strategies in the healthcare sector. With a background in molecular biology, Michael has transitioned successfully from a gene therapy scientist to a key player in healthcare finance. Learn how his scientific insights have fueled the creation of Pink, a groundbreaking healthcare ETF that supports breast cancer research through the Susan G. Kom...